Tracy Cardillo

1.4k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

Tracy Cardillo is a scholar working on Dermatology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, Tracy Cardillo has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 5 papers in Rheumatology and 5 papers in Immunology and Allergy. Recurrent topics in Tracy Cardillo's work include Dermatology and Skin Diseases (8 papers), Food Allergy and Anaphylaxis Research (4 papers) and Allergic Rhinitis and Sensitization (4 papers). Tracy Cardillo is often cited by papers focused on Dermatology and Skin Diseases (8 papers), Food Allergy and Anaphylaxis Research (4 papers) and Allergic Rhinitis and Sensitization (4 papers). Tracy Cardillo collaborates with scholars based in United States, Japan and Germany. Tracy Cardillo's co-authors include William L. Macias, Terence Rooney, Mark C. Genovese, Josef S Smolen, Douglas Schlichting, Scott D. Beattie, Joel Kremer, Stephanie de Bono, Charles Ludivico and Marek Krogulec and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Tracy Cardillo

11 papers receiving 1.0k citations

Hit Papers

Baricitinib in Patients with Refractory Rheumatoid Arthritis 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Baricitinib in Patients with Refractory Rheumatoid Arthritis
    2016 458 citations Mark C. Genovese, Joel Kremer et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tracy Cardillo United States 9 547 252 220 200 173 13 1.1k
R. Fleischmann United States 11 840 1.5× 300 1.2× 324 1.5× 205 1.0× 136 0.8× 38 1.5k
Elisa Menegatti Italy 21 479 0.9× 171 0.7× 257 1.2× 104 0.5× 13 0.1× 76 1.3k
Zhaoyue Wang China 19 69 0.1× 379 1.5× 190 0.9× 174 0.9× 32 0.2× 91 1.2k
Melanie Poulin-Costello Canada 14 120 0.2× 137 0.5× 253 1.1× 426 2.1× 88 0.5× 36 1.1k
Giuseppe Papa Italy 18 148 0.3× 310 1.2× 138 0.6× 137 0.7× 226 1.3× 36 1.1k
Maria Silk United States 10 576 1.1× 79 0.3× 376 1.7× 218 1.1× 21 0.1× 18 884
F. Matzkies Germany 15 624 1.1× 263 1.0× 184 0.8× 232 1.2× 38 0.2× 69 1.0k
Erhard Quebe‐Fehling Switzerland 15 158 0.3× 177 0.7× 80 0.4× 1.2k 5.8× 46 0.3× 42 1.9k
Irene Cecchi Italy 18 731 1.3× 342 1.4× 275 1.3× 49 0.2× 9 0.1× 83 1.1k
Stanley J. Marciniak United States 11 150 0.3× 165 0.7× 373 1.7× 82 0.4× 183 1.1× 19 773

Countries citing papers authored by Tracy Cardillo

Since Specialization
Citations

This map shows the geographic impact of Tracy Cardillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy Cardillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy Cardillo more than expected).

Fields of papers citing papers by Tracy Cardillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy Cardillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy Cardillo. The network helps show where Tracy Cardillo may publish in the future.

Co-authorship network of co-authors of Tracy Cardillo

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy Cardillo. A scholar is included among the top collaborators of Tracy Cardillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy Cardillo. Tracy Cardillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Bieber, Thomas, Norito Katoh, Eric L. Simpson, et al.. (2022). Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials. Journal of Dermatological Treatment. 34(1). 2161812–2161812. 32 indexed citations
3.
Silverberg, Jonathan I., Robert Bissonnette, Kenji Kabashima, et al.. (2022). 33542 Stability of response prior to baricitinib downtitration or treatment withdrawal: Outcome from a substudy of BREEZE AD3. Journal of the American Academy of Dermatology. 87(3). AB205–AB205.
4.
Silverberg, Jonathan I., Eric L. Simpson, Jacob P. Thyssen, et al.. (2022). Long‐term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate‐to‐severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE‐AD7. Journal of the European Academy of Dermatology and Venereology. 37(5). 1036–1045. 8 indexed citations
5.
King, Brett, Catherine Maari, Edward Lain, et al.. (2021). Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials. American Journal of Clinical Dermatology. 22(3). 395–405. 32 indexed citations
6.
Silverberg, Jonathan I., Eric L. Simpson, Andreas Wollenberg, et al.. (2021). Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders. JAMA Dermatology. 157(6). 691–691. 69 indexed citations
7.
Maari, Catherine, Edward Lain, Jonathan I. Silverberg, et al.. (2021). 27030 Extended safety analysis of baricitinib 2-mg in adult patients with atopic dermatitis: An integrated analysis from 8 randomized clinical trials. Journal of the American Academy of Dermatology. 85(3). AB127–AB127. 1 indexed citations
8.
Emery, Paul, Yoshiya Tanaka, Tracy Cardillo, et al.. (2020). Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 115–115. 14 indexed citations
9.
10.
Smolen, Josef S, Mark C. Genovese, Tsutomu Takeuchi, et al.. (2018). Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment. The Journal of Rheumatology. 46(1). 7–18. 206 indexed citations
11.
Tuttle, Katherine R., Frank C. Brosius, Sharon G. Adler, et al.. (2017). JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. Nephrology Dialysis Transplantation. 33(11). 1950–1959. 210 indexed citations
12.
Genovese, Mark C., Joel Kremer, Omid Zamani, et al.. (2016). Baricitinib in Patients with Refractory Rheumatoid Arthritis. New England Journal of Medicine. 374(13). 1243–1252. 458 indexed citations breakdown →
13.
Diodati, Jean G., Jorge F. Saucedo, J. French, et al.. (2013). Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose Alone. Circulation Cardiovascular Interventions. 6(5). 567–574. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Fleischmann Breakdown of academic impact, for papers by Elisa Menegatti Breakdown of academic impact, for papers by Zhaoyue Wang Breakdown of academic impact, for papers by Melanie Poulin-Costello Breakdown of academic impact, for papers by Giuseppe Papa Breakdown of academic impact, for papers by Maria Silk Breakdown of academic impact, for papers by F. Matzkies Breakdown of academic impact, for papers by Erhard Quebe‐Fehling Breakdown of academic impact, for papers by Irene Cecchi Breakdown of academic impact, for papers by Stanley J. Marciniak
Rankless by CCL
2026